A detailed history of Rmb Capital Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Rmb Capital Management, LLC holds 13,096 shares of NVO stock, worth $1.14 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
13,096
Previous 13,288 1.44%
Holding current value
$1.14 Million
Previous $1.9 Million 17.77%
% of portfolio
0.04%
Previous 0.05%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$119.07 - $145.42 $22,861 - $27,920
-192 Reduced 1.44%
13,096 $1.56 Million
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $206,766 - $247,543
1,685 Added 14.52%
13,288 $1.9 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $195,540 - $260,286
1,915 Added 19.77%
11,603 $1.49 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $126,578 - $152,058
1,442 Added 17.49%
9,688 $1 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $394,679 - $866,003
4,340 Added 111.11%
8,246 $749,000
Q2 2023

Aug 11, 2023

SELL
$155.98 - $172.65 $22,149 - $24,516
-142 Reduced 3.51%
3,906 $632,000
Q1 2023

May 11, 2023

SELL
$132.34 - $159.14 $25,806 - $31,032
-195 Reduced 4.6%
4,048 $644,000
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $137,006 - $180,800
1,336 Added 45.96%
4,243 $574,000
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $9,051 - $11,108
95 Added 3.38%
2,907 $290,000
Q2 2021

Aug 13, 2021

SELL
$67.66 - $84.76 $86,807 - $108,747
-1,283 Reduced 31.33%
2,812 $236,000
Q1 2021

May 12, 2021

SELL
$67.06 - $75.82 $84,830 - $95,912
-1,265 Reduced 23.6%
4,095 $276,000
Q4 2020

Feb 11, 2021

SELL
$63.89 - $73.8 $511 - $590
-8 Reduced 0.15%
5,360 $374,000
Q3 2020

Nov 10, 2020

BUY
$63.69 - $70.22 $509 - $561
8 Added 0.15%
5,368 $373,000
Q2 2020

Aug 05, 2020

SELL
$58.54 - $67.94 $73,643 - $85,468
-1,258 Reduced 19.01%
5,360 $351,000
Q1 2020

May 11, 2020

BUY
$49.46 - $64.78 $50,102 - $65,622
1,013 Added 18.07%
6,618 $399,000
Q4 2019

Feb 13, 2020

SELL
$49.86 - $58.26 $22,387 - $26,158
-449 Reduced 7.42%
5,605 $325,000
Q2 2019

Aug 13, 2019

SELL
$46.79 - $52.47 $4,772 - $5,351
-102 Reduced 1.66%
6,054 $309,000
Q1 2019

May 15, 2019

SELL
$46.36 - $52.63 $49,187 - $55,840
-1,061 Reduced 14.7%
6,156 $322,000
Q4 2018

Feb 13, 2019

SELL
$41.54 - $47.25 $1,080 - $1,228
-26 Reduced 0.36%
7,217 $333,000
Q3 2018

Nov 14, 2018

SELL
$46.76 - $51.24 $87,067 - $95,408
-1,862 Reduced 20.45%
7,243 $341,000
Q2 2018

Aug 13, 2018

BUY
$44.29 - $50.42 $86,011 - $97,915
1,942 Added 27.11%
9,105 $0
Q1 2018

May 14, 2018

SELL
$48.49 - $58.14 $3,297 - $3,953
-68 Reduced 0.94%
7,163 $352,000
Q4 2017

Feb 14, 2018

BUY
$47.53 - $53.73 $343,689 - $388,521
7,231
7,231 $389,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Rmb Capital Management, LLC Portfolio

Follow Rmb Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rmb Capital Management, LLC with notifications on news.